Braeburn Inc. NDCs and Package Codes
This page lists NDC package records associated with labeler code 58284 (Braeburn Inc.) — including active listings, ingredients, drug names, strengths, dosage forms, package sizes, pricing data when available, and links to each individual NDC page.
Key stats
7
Package NDCs
7
Products
7
Active listings
0
Discontinued
1
Ingredients
0
Therapeutic classes
1
Dosage forms
0
With NADAC pricing
Portfolio
Top ingredients
By dosage form
Browse records — 7 products
| Drug / product | Billing NDC | NADAC / unit | Status | |
|---|---|---|---|---|
| BRIXADI BUPRENORPHINE 24 mg/.48mL INJECTION | 58284-0224-01 | — | On market | View → |
| BRIXADI BUPRENORPHINE 16 mg/.32mL INJECTION | 58284-0216-01 | — | On market | View → |
| BRIXADI BUPRENORPHINE 32 mg/.64mL INJECTION | 58284-0232-01 | — | On market | View → |
| BRIXADI BUPRENORPHINE 64 mg/.18mL INJECTION | 58284-0264-01 | — | On market | View → |
| BRIXADI BUPRENORPHINE 8 mg/.16mL INJECTION | 58284-0208-01 | — | On market | View → |
| BRIXADI BUPRENORPHINE 128 mg/.36mL INJECTION | 58284-0228-01 | — | On market | View → |
| BRIXADI BUPRENORPHINE 96 mg/.27mL INJECTION | 58284-0296-01 | — | On market | View → |
Where does this data come from?
NDC package records, ingredients, strengths and forms come from the openFDA NDC Directory, grouped by the 5-digit labeler code; pricing is CMS NADAC. This is a factual data directory, not a manufacturer marketing page.